Willie Yu
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Gene expression and cancer classification 4
- Finance 8
- Financial Markets and Investment Strategies 7
- Financial Risk and Volatility Modeling 4
- Credit Risk and Financial Regulations 2
- Co-authors
- Steve Rozen (11 shared papers)Zura Kakushadze (15 shared papers)Bin Tean Teh (8 shared papers)Patrick Tan (6 shared papers)Song Ling Poon (4 shared papers)Arnoud Boot (4 shared papers)Alvin Wei Tian Ng (3 shared papers)Mi Ni Huang (2 shared papers)
- Journals
- Genome Research (2 papers)Journal of Lipid Research (1 paper)Clinical Cancer Research (1 paper)Biochemical and Biophysical Research Communications (1 paper)Cancer Medicine (1 paper)
- Partner nations
- SingaporeUnited StatesTaiwan
In The Last Decade
Willie Yu
26 papers receiving 1.2k citations
Willie Yu's Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 334
- Pharmacology 125
- Nephrology 65
- Radiology, Nuclear Medicine and Imaging 186
- Molecular Biology 525
Countries citing papers authored by Willie Yu
This map shows the geographic impact of Willie Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willie Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willie Yu more than expected).
Fields of papers citing papers by Willie Yu
This network shows the impact of papers produced by Willie Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willie Yu. The network helps show where Willie Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Willie Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia Hit paper breakdown → | 2017 | 288 |
| 2 | 2017 | 271 | |
| 3 | 2014 | 100 | |
| 4 | 2017 | 83 | |
| 5 | 2015 | 78 | |
| 6 | 2014 | 77 | |
| 7 | 2010 | 69 | |
| 8 | 2017 | 65 | |
| 9 | 2020 | 37 | |
| 10 | 2006 | 34 | |
| 11 | 2022 | 30 | |
| 12 | 2017 | 30 | |
| 13 | 2015 | 28 | |
| 14 | 2011 | 16 | |
| 15 | 2006 | 13 | |
| 16 | 2016 | 7 | |
| 17 | 2016 | 7 | |
| 18 | 2016 | 7 | |
| 19 | 2017 | 6 | |
| 20 | 2024 | 5 |
About Willie Yu
Willie Yu is a scholar working on Molecular Biology, Finance, Economics and Econometrics, Cancer Research and Management Science and Operations Research, having authored 29 papers that have together received 1.3k indexed citations. Recurring topics across this work include Financial Markets and Investment Strategies (7 papers), Cancer Genomics and Diagnostics (4 papers), Gene expression and cancer classification (4 papers), Financial Risk and Volatility Modeling (4 papers), Complex Systems and Time Series Analysis (3 papers), Credit Risk and Financial Regulations (2 papers), Neuroblastoma Research and Treatments (2 papers) and Nephrotoxicity and Medicinal Plants (2 papers). The work is most often cited by research in Cancer Research (334 citations), Pharmacology (125 citations), Nephrology (65 citations), Radiology, Nuclear Medicine and Imaging (186 citations) and Molecular Biology (525 citations). Willie Yu has collaborated with scholars based in Singapore, United States and Taiwan. Frequent co-authors include Steve Rozen, Zura Kakushadze, Bin Tean Teh, Patrick Tan, Song Ling Poon, Arnoud Boot, Alvin Wei Tian Ng, Mi Ni Huang, Xiaochun Zhang and Jianxin Lyu. Their work appears in journals such as Genome Research, Journal of Lipid Research, Clinical Cancer Research, Biochemical and Biophysical Research Communications and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.